In this research study, we are evaluating the effectiveness and safety of an investigational drug called aripriprazole; this drug was approved in the U.S. in 2014 for the treatment of Tourette's Disorder in 6 to 18 year olds.
All medical examinations and medication at no cost
Financial compensation provided for time and travel upon completion of study visits*
*Based on qualification and enrollment into study
What to Expect
The Purpose of this Study
If you think you qualify for this study, contact us for a screening: